LabGenomics Co., Ltd. (KOSDAQ:084650)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,368.00
+28.00 (2.09%)
Apr 29, 2026, 3:30 PM KST
-36.52%
Market Cap 101.56B
Revenue (ttm) 88.16B
Net Income (ttm) -64.37B
Shares Out 74.24M
EPS (ttm) -867.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,098,011
Average Volume 6,009,602
Open 1,341.00
Previous Close 1,340.00
Day's Range 1,340.00 - 1,394.00
52-Week Range 1,209.00 - 3,285.00
Beta 0.12
RSI 47.52
Earnings Date Apr 3, 2026

About LabGenomics

LabGenomics Co., Ltd. engages in the research and development of biotechnology products in South Korea. It is also involved in the sale of diagnostic devices. The company was founded in 2002 and is based in Seongnam-si, South Korea. [Read more]

Industry Medical - Specialties
Sector Healthcare
Founded 2002
Employees 142
Stock Exchange KOSDAQ
Ticker Symbol 084650
Full Company Profile

Financial Performance

In 2025, LabGenomics's revenue was 88.16 billion, an increase of 2.63% compared to the previous year's 85.90 billion. Losses were -64.37 billion, 170.5% more than in 2024.

Financial Statements

News

There is no news available yet.